---
$id: https://graph.org.ai/products/commodity/51392209
$type: Product
source: UNSPSC
code: "51392209"
title: "Dexlofexidine or levlofexidine or lofexidine"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dexlofexidine or levlofexidine or lofexidine

**UNSPSC Code**: 51392209
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5SPW497X0Z, chemically known as (-)-(r)-2-(1-(2,6-dichlorophenoxy)ethyl)-2-imidazoline. but generally known as levlofexidine, which bears US NIH Compound Identifier 3038503. European Medicines Agency schedules Levlofexidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08461MIG. The term LEVLOFEXIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). LEVLOFEXIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl.

